Progression-free survival estimation of docetaxel-based second-line treatment for advanced non-small cell lung cancer: a pooled analysis from 18 randomized control trials

Overview of attention for article published in Frontiers in oncology, May 2024

Altmetric Badge

Mentioned by

reddit: 1 Redditor

Readers on

mendeley: 2 Mendeley

So far, Altmetric has seen 1 Reddit thread.

Frontiers | Progression-free survival estimation of docetaxel-based second-line treatment for advanced non-small cell lung cancer: a pooled analysis from 18 randomized control trials

User WalkingHorse, in the LungCancerSupport subreddit, 29 May 2024

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.